Thyroid Cancer

CHICAGO — Glucagon-like peptide-1 receptor agonists lowered the risk for obesity-related cancers compared with bariatric surgery among individuals with a BMI of at least 35, according to data presented at ASCO Annual Meeting.

The FDA granted accelerated approval to selpercatinib for the treatment of certain pediatric patients with metastatic or advanced solid tumors harboring RET alterations.

NEW ORLEANS —New risk stratification guidance for classifying thyroid nodules may come soon as imaging technology continues to evolve, according to a speaker at the AACE annual meeting.

Allen S. Ho, MD, did not wait to promote active surveillance when he started practicing medicine a decade ago.

Adults who initiate a GLP-1 receptor agonist have a similar risk for developing thyroid cancer as those prescribed a DPP-IV inhibitor or an SGLT2 inhibitor, according to study findings published in The BMJ.

Adults who develop hypoparathyroidism after a total thyroidectomy have an increased risk for all-cause mortality compared with the general population, but only if the indication for their surgery was cancer, according to study data.

Adults who were exposed to higher levels of endocrine-disrupting chemicals were more likely to be diagnosed with thyroid cancer, according to a study published in eBioMedicine.

Exposure to a class of endocrine-disrupting chemicals may increase the risk for developing thyroid cancer, according to a study published in eBioMedicine.

Roughly 500,000 people living in the United States have survived childhood cancer, a consequence of improved research, innovations and treatments.

The offspring of adolescent and young adult women with a history of cancer experienced a higher risk for birth defects, according to study results published in Cancer Epidemiology, Biomarkers & Prevention.